- List
- By Topic
- On Map
- Search Details

ULIPRISTAL (174 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT03802149 | Not yet recruiting | Ulipristal Acetate for Cervical Preparation |
|
|
Interventional |
Early Phase 1 |
|
Other |
|
|
25 | Female | 18 Years and older (Adult, Older Adult) | NCT03802149 | IRB-48756 | U-Prep | February 2019 | February 2020 | February 2020 | January 14, 2019 | January 15, 2019 | |||
2 | NCT03325868 | Withdrawn | Effect of Ulipristal Acetate on Bleeding Patterns and Dysmenorrhea in Women With Adenomyosis |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
0 | Female | 18 Years to 51 Years (Adult) | NCT03325868 | Ulipristal | February 2018 | May 2019 | May 2019 | October 30, 2017 | February 8, 2018 |
|
|||
3 | NCT02213081 | Unknown † | Ulipristal for Endometriosis-related Pelvic Pain |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
25 | Female | 18 Years to 50 Years (Adult) | NCT02213081 | STU00091840 | February 2015 | June 2017 | June 2018 | August 11, 2014 | September 29, 2016 |
|
|||
4 | NCT03296098 | Not yet recruiting | Study of the Safety and Efficacy of Ulipristal Acetate (UPA) Used Daily as a Contraceptive |
|
|
Interventional |
Phase 2 |
|
Other / NIH |
|
|
300 | Female | 18 Years to 35 Years (Adult) | NCT03296098 | CCN013B | CCN013B | December 2018 | September 2020 | December 2020 | September 28, 2017 | August 2, 2018 |
|
||
5 | NCT02361905 | Unknown † | Ulipristal Acetate for the Preoperative Management of Hypoechoic Cellular Leiomyomas |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
42 | Female | 18 Years to 55 Years (Adult) | NCT02361905 | UPA hypoecoic myomas | February 2015 | September 2017 | September 2017 | February 12, 2015 | November 18, 2016 |
|
|||
6 | NCT02517463 | Completed Has Results |
Ulipristal Emergency Contraception Used Before or After Ovulation |
|
|
Observational |
|
Other |
|
|
700 | Female | 18 Years and older (Adult, Older Adult) | NCT02517463 | UW10-392 | May 2011 | April 2014 | April 2014 | August 7, 2015 | July 30, 2018 | July 30, 2018 | ||||
7 | NCT02587000 | Unknown † | Adenomyosis and Ulipristal Acetate |
|
|
Interventional |
Phase 2 |
|
Other / Industry |
|
|
48 | Female | 30 Years to 50 Years (Adult) | NCT02587000 | P141201 2014-004403-75 |
FRA-IIT-UPA | May 2015 | December 2017 | December 2017 | October 27, 2015 | September 12, 2017 |
|
||
8 | NCT02922127 | Recruiting | Compare Daily Ulipristal Acetate and Combined Oral Contraceptive Effects on Breast Epithelial Cell Proliferation |
|
|
Interventional |
Phase 1 |
|
Other |
|
|
45 | Female | 18 Years to 39 Years (Adult) | NCT02922127 | AAAQ8498 | December 16, 2016 | June 2020 | June 2020 | October 4, 2016 | November 8, 2017 |
|
|||
9 | NCT02361879 | Unknown † | Ulipristal Acetate Versus GnRH Analogue Treatment Before Hysteroscopic Resection of Uterine Leiomyoma |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
146 | Female | 18 Years to 55 Years (Adult) | NCT02361879 | UPA and hysteroscopy | February 2015 | September 2017 | September 2017 | February 12, 2015 | November 18, 2016 |
|
|||
10 | NCT03354117 | Recruiting | On Demand Contraception: Ulipristal Acetate Plus a COX-2 Inhibitor at Peak Fertility |
|
|
Interventional |
Phase 1 |
|
Other |
|
|
20 | Female | 18 Years to 35 Years (Adult) | NCT03354117 | 43881 | March 15, 2018 | July 31, 2019 | July 31, 2019 | November 27, 2017 | June 5, 2018 |
|
|||
11 | NCT02288130 | Unknown † | Ulipristal vs. GnRHa Prior to Laparoscopic Myomectomy |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
100 | Female | 18 Years and older (Adult, Older Adult) | NCT02288130 | 2014.421 | MYOMEX | December 2014 | July 2017 | November 2017 | November 11, 2014 | November 3, 2016 |
|
||
12 | NCT03342859 | Recruiting | Mode of Action Study of Vilaprisan and Ulipristal Acetate in Patients With Uterine Fibroids for Whom Surgery is Planned |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
55 | Female | 18 Years and older (Adult, Older Adult) | NCT03342859 | 15791 2017-000468-13 |
November 16, 2017 | August 30, 2020 | October 6, 2020 | November 17, 2017 | February 5, 2019 |
|
|||
13 | NCT02357563 | Unknown † | Ulipristal Acetate Versus GnRH Analogue and Myometrial Preservation |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
110 | Female | 18 Years to 40 Years (Adult) | NCT02357563 | UPA myometrial | February 2015 | September 2017 | September 2017 | February 6, 2015 | November 18, 2016 |
|
|||
14 | NCT03118297 | Completed Has Results |
Intervention to End Recurrent Unscheduled Bleeding Trial |
|
|
Interventional |
Phase 3 |
|
Other |
|
|
65 | Female | 18 Years to 45 Years (Adult) | NCT03118297 | 201612002 | INTERRUPT | May 1, 2017 | January 31, 2018 | January 31, 2018 | April 18, 2017 | August 31, 2018 | August 31, 2018 |
|
|
15 | NCT02601196 | Unknown † | IVF Outcome Following Treatment With Ulipristal Acetate for Myomatous Uterus After at Least One IVF Failure |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
20 | Female | 18 Years to 44 Years (Adult) | NCT02601196 | SHEBA-15-2101-EZ-CTIL | September 2016 | January 2018 | January 2018 | November 10, 2015 | July 12, 2016 | ||||
16 | NCT02451826 | Active, not recruiting | A Study to Evaluate the Effect of a Contraceptive Vaginal Ring Delivering Ulipristal Acetate Combined With a Single or Repeated Levonorgestrel on Inhibition of Ovulation, Endometrial Changes and Bleeding Patterns in Normal Cycling Women |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
19 | Female | 21 Years to 35 Years (Adult) | NCT02451826 | 674 | May 2015 | November 1, 2017 | December 31, 2017 | May 22, 2015 | August 15, 2017 |
|
|||
17 | NCT01391845 | Unknown † | Ulipristal Acetate on Progesterone Levels and Glycodelin-A Endometrial Pattern |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
16 | Female | 21 Years to 35 Years (Adult) | NCT01391845 | ist1979 | July 2011 | March 2012 | June 2012 | July 12, 2011 | July 20, 2011 |
|
|||
18 | NCT03349190 | Completed | Impact of Esmya on Fertility to Infertile Women With Fibroids Managed With Assisted Reproduction Techniques |
|
|
Observational |
|
Other / Industry |
|
|
127 | Female | 18 Years to 43 Years (Adult) | NCT03349190 | 0001 | NACRE | December 29, 2017 | June 30, 2018 | January 8, 2019 | November 21, 2017 | January 9, 2019 |
|
|||
19 | NCT02825719 | Active, not recruiting | Ulipristal Use in Chinese Population |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
31 | Female | 18 Years and older (Adult, Older Adult) | NCT02825719 | UW 15-022 | December 2, 2015 | December 2018 | December 2018 | July 7, 2016 | April 6, 2018 |
|
|||
20 | NCT03208985 | Completed | A Study of Use of Ella®, an Emergency Contraceptive, Under Simulated OTC Conditions |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
768 | Female | Child, Adult, Older Adult | NCT03208985 | 151032-001 | LIBRella | May 23, 2017 | June 14, 2018 | June 14, 2018 | July 6, 2017 | August 6, 2018 |
|
||
21 | NCT02634437 | Completed | Study of Ulipristal Acetate in Female Patients With Moderately or Severely Impaired Renal Function, Compared With Matched Healthy Female Subjects |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
19 | Female | 18 Years to 80 Years (Adult, Older Adult) | NCT02634437 | UPA-PK-02 | December 1, 2015 | December 9, 2016 | December 9, 2016 | December 18, 2015 | February 8, 2018 |
|
|||
22 | NCT03186586 | Recruiting | Ulipristal Versus Placebo for Women With Bleeding Induced by Mirena |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
32 | Female | 18 Years to 45 Years (Adult) | NCT03186586 | CEMICAMP | July 1, 2017 | July 30, 2018 | July 30, 2018 | June 14, 2017 | May 3, 2018 |
|
|||
23 | NCT02361892 | Unknown † | The Effect of Ulipristal Acetate (UPA) on Women Ovarian Reserve |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
73 | Female | 18 Years to 40 Years (Adult) | NCT02361892 | UPA and ovarian reserve | UPA_ovAge | February 2015 | June 2017 | September 2017 | February 12, 2015 | November 18, 2016 |
|
||
24 | NCT02408770 | Unknown † | Breast Cancer - Anti-Progestin Prevention Study 1 |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
30 | Female | 25 Years to 45 Years (Adult) | NCT02408770 | UHSM0315 | BC-APPS1 | September 2015 | December 2016 | May 2017 | April 3, 2015 | October 27, 2015 | |||
25 | NCT02147197 | Completed | A Study of the Efficacy and Safety of a Single Ulipristal Treatment Course for the Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
144 | Female | 18 Years to 50 Years (Adult) | NCT02147197 | UL1309 | April 2014 | March 2016 | April 2016 | May 26, 2014 | March 20, 2017 |
|
|||
26 | NCT01953679 | Completed | Efficacy Study of Two Continuous Regimens of Oral Daily 5 mg or 10 mg of Ulipristal Acetate (UPA), Versus a Dose of 5.0mg UPA for 24/4 Days |
|
|
Interventional |
Phase 2 |
|
Other / NIH |
|
|
180 | Female | 18 Years to 35 Years (Adult) | NCT01953679 | CCN013 | CCN013 | March 2014 | August 2015 | November 2015 | October 1, 2013 | February 22, 2016 |
|
||
27 | NCT00290251 | Completed Has Results |
Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914 |
|
|
Interventional |
Phase 2 |
|
NIH / Industry |
|
|
72 | Female | 25 Years to 50 Years (Adult) | NCT00290251 | 060090 1ZIAHD000637-17 06-CH-0090 |
February 2006 | July 2009 | August 2010 | February 10, 2006 | December 18, 2012 | December 18, 2012 |
|
||
28 | NCT01642472 | Completed | PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
64 | Female | 18 Years and older (Adult, Older Adult) | NCT01642472 | PGL11-024 | PEARLext2 | July 2012 | March 2015 | April 2015 | July 17, 2012 | January 8, 2016 |
|
||
29 | NCT01553123 | Withdrawn | Efficacy and Safety Study of Ulipristal Acetate in Females With Anemia Associated With Uterine Leiomyoma |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
0 | Female | 18 Years to 50 Years (Adult) | NCT01553123 | UL1104 | April 2012 | November 2013 | December 2013 | March 13, 2012 | February 7, 2013 |
|
|||
30 | NCT01569737 | Completed | Clinical Follow-up and Outcomes of Pregnancies Exposed to Ella |
|
|
Observational |
|
Industry |
|
|
98 | Female | 18 Years and older (Adult, Older Adult) | NCT01569737 | 2914-012 | ellipse II | January 2012 | June 29, 2018 | June 29, 2018 | April 3, 2012 | July 30, 2018 |
|
|||
31 | NCT03421639 | Recruiting | Aromatase Plus GnRH Analogue Versus Ulippristal Acetate in Uterine Fibroids |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
150 | Female | 30 Years to 45 Years (Adult) | NCT03421639 | CR-01-18 | December 1, 2017 | January 31, 2019 | February 1, 2020 | February 5, 2018 | February 7, 2018 |
|
|||
32 | NCT03027973 | Not yet recruiting | Quality of Life Outcomes for Ulipristal Acetate and Tranexamic Acid in the Management of Heavy Menstrual Bleeding |
|
|
Interventional |
Phase 1 |
|
Other |
|
|
60 | Female | 18 Years to 51 Years (Adult) | NCT03027973 | PBLL07230904 16-155 |
March 2018 | December 2018 | July 2019 | January 23, 2017 | November 17, 2017 |
|
|||
33 | NCT02425878 | Completed | Ulipristal Acetate 10 mg and Asisted Reproduction |
|
|
Interventional |
Phase 3 |
|
Other |
|
|
2 | Female | 18 Years to 50 Years (Adult) | NCT02425878 | 1311-BCN-138-DG | May 2015 | May 2016 | May 2016 | April 24, 2015 | August 30, 2016 |
|
|||
34 | NCT02147158 | Completed | A Study of the Safety and Efficacy of Intermittent Ulipristal Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
432 | Female | 18 Years to 50 Years (Adult) | NCT02147158 | UL1208 | January 29, 2014 | November 24, 2016 | January 3, 2017 | May 26, 2014 | November 7, 2017 |
|
|||
35 | NCT03156127 | Withdrawn | A Study to Compare the Pharmacokinetics and Safety/Tolerability of BR-UPS (Ulipristal Acetate) 5 mg Tablet With Inisia (Ulipristal Acetate) 5 mg Tablet |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
0 | Female | 19 Years to 45 Years (Adult) | NCT03156127 | BR-UPS-CT-101 | May 19, 2017 | July 2017 | October 2017 | May 17, 2017 | August 10, 2017 |
|
|||
36 | NCT00791297 | Completed | Study to Evaluate the Safety and Efficacy of Two Contraceptive Vaginal Rings Delivering a Daily Dose of 1500 or 2500 μg of CDB-2914 |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
55 | Female | 21 Years to 40 Years (Adult) | NCT00791297 | Population Council #422 | October 2008 | September 2014 | September 2014 | November 14, 2008 | August 15, 2017 |
|
|||
37 | NCT02577601 | Completed Has Results |
Impact of Combined Hormonal Contraceptives on UPA |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
36 | Female | 18 Years to 35 Years (Adult) | NCT02577601 | OHSU IRB 11784 | September 8, 2015 | June 17, 2017 | June 17, 2017 | October 16, 2015 | December 31, 2018 | December 31, 2018 |
|
||
38 | NCT01493791 | Withdrawn | CDB-2914 for Abnormal Uterine Bleeding in Premenopausal Women |
|
|
Interventional |
Early Phase 1 |
|
NIH |
|
|
0 | All | 25 Years to 50 Years (Adult) | NCT01493791 | 120015 12-CH-0015 |
November 8, 2011 | July 24, 2013 | July 24, 2013 | December 16, 2011 | February 15, 2019 | ||||
39 | NCT01539720 | Completed | Levonorgestrel Intrauterine System For Emergency Contraception |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
273 | Female | 14 Years to 45 Years (Child, Adult) | NCT01539720 | 201201007 | LIFE | December 2012 | November 30, 2018 | November 30, 2018 | February 27, 2012 | December 3, 2018 |
|
||
40 | NCT02689804 | Completed Has Results |
EC PK in Women With Normal and Obese BMI |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
34 | Female | 18 Years to 45 Years (Adult) | NCT02689804 | AAAP1857 | July 10, 2015 | December 29, 2015 | February 3, 2017 | February 24, 2016 | July 7, 2017 | July 7, 2017 |
|
||
41 | NCT01107106 | Completed | Safety, Tolerability, and Efficacy of ellaOne® (Ulipristal Acetate) for Emergency Contraception in Postmenarcheal Adolescent Girls and Women |
|
|
Observational |
|
Industry |
|
|
579 | Female | Child, Adult, Older Adult | NCT01107106 | 2914-010 2009-017771-21 |
May 2010 | January 2013 | February 2013 | April 20, 2010 | May 15, 2013 |
|
||||
42 | NCT01107093 | Completed | Comparison of CDB-2914 Versus Placebo in the Prevention of Follicular Rupture Post-luteinizing Hormone (LH) Surge |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
35 | Female | 18 Years to 35 Years (Adult) | NCT01107093 | 2914-007 | May 2008 | December 2008 | December 2008 | April 20, 2010 | August 25, 2010 |
|
|||
43 | NCT01337206 | Completed | SX ELLA Esophageal Degradable BD Stent System |
|
|
Interventional |
Not Applicable |
|
Industry |
|
|
66 | All | 18 Years and older (Adult, Older Adult) | NCT01337206 | 09-024 | DESTINY | January 2012 | July 2014 | January 2015 | April 18, 2011 | February 6, 2015 |
|
||
44 | NCT02440750 | Unknown † | Endometrial Preparation Before Operative Hysteroscopy in Premenopausal Women |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
50 | Female | 18 Years to 50 Years (Adult) | NCT02440750 | HYSTERO | June 2016 | April 2017 | June 2017 | May 12, 2015 | March 9, 2016 | ||||
45 | NCT03230539 | Recruiting | A proof-of Concept, Randomized 3-month Study to Evaluate the Effects of Three Contraceptive Intrauterine Systems Delivering Copper and a Daily Dose of 5, 20 or 40 μg of Ulipristal Acetate (UPA) |
|
|
Interventional |
Phase 1 |
|
Other |
|
|
30 | Female | 21 Years to 38 Years (Adult) | NCT03230539 | 719 | May 1, 2017 | January 2018 | May 2018 | July 26, 2017 | August 15, 2017 |
|
|||
46 | NCT02748460 | Recruiting | Non-interventional Study to Evaluate Long Term Safety, Prescription Management Patterns of Esmya in a Long Term Setting |
|
Observational |
|
Industry |
|
|
1500 | Female | 18 Years and older (Adult, Older Adult) | NCT02748460 | PGL14-001 (PREMIUM) | Premium | December 2015 | December 2022 | December 2022 | April 22, 2016 | December 8, 2016 |
|
||||
47 | NCT03533907 | Completed | Pregnancy Outcomes in Infertile Patients After Treatment With Ulipristal Acetate. |
|
Observational |
|
Other |
|
|
20 | Female | 18 Years to 45 Years (Adult) | NCT03533907 | 8/2018 | November 1, 2013 | April 10, 2018 | May 1, 2018 | May 23, 2018 | June 8, 2018 |
|
|||||
48 | NCT02600286 | Terminated | Ulipristal Acetate In Disease Charcot-Marie-Tooth Type of 1A |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
23 | Male | 18 Years to 70 Years (Adult, Older Adult) | NCT02600286 | 6100 | UPACOMT | October 23, 2015 | November 2017 | November 2, 2017 | November 9, 2015 | May 25, 2018 |
|
||
49 | NCT00456924 | Completed | Low Dose Continuous Administration of the Progesterone Receptor Modulator VA2914 |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
48 | Female | 18 Years to 35 Years (Adult) | NCT00456924 | 2914-002 | January 2004 | December 2004 | April 5, 2007 | June 17, 2010 |
|
||||
50 | NCT00411684 | Completed | Safety and Efficacy of CDB-2914 for Emergency Contraception |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
1320 | Female | 18 Years and older (Adult, Older Adult) | NCT00411684 | 2914-005 | November 2006 | December 14, 2006 | June 17, 2010 |
|
|||||
51 | NCT00009659 | Completed | Use of the Synthetic Hormone CDB-2914 in Treating Symptoms of Menopause |
|
|
Interventional |
Phase 2 |
|
NIH |
|
58 | Female | Child, Adult, Older Adult | NCT00009659 | 010081 01-CH-0081 |
January 2001 | December 2001 | February 5, 2001 | March 4, 2008 |
|
|||||
52 | NCT00044876 | Completed | Treatment of Uterine Fibroids With CDB-2914, an Experimental Selective Progesterone Receptor Antagonist |
|
|
Interventional |
Phase 2 |
|
NIH |
|
56 | Female | 33 Years to 50 Years (Adult) | NCT00044876 | 020287 02-CH-0287 |
September 2, 2002 | June 16, 2007 | October 1, 2015 | September 6, 2002 | February 15, 2019 |
|
||||
53 | NCT00271583 | Completed | Efficacy Trial of CDB 2914 for Emergency Contraception |
|
|
Interventional |
Phase 2 Phase 3 |
|
Other / NIH |
|
|
1672 | Female | 18 Years and older (Adult, Older Adult) | NCT00271583 | CCN002 N01-HD-9-3298 |
September 1999 | September 2001 | January 2, 2006 | December 17, 2007 |
|
||||
54 | NCT01635452 | Unknown † | A Prospective Multicenter Non-interventional Study of Women Treated With ESMYA (Ulipristal Acetate) as Pre-operative Treatment of Moderate to Severe Symptoms of Uterine Fibroids |
|
Observational |
|
Industry |
|
|
1500 | Female | 18 Years and older (Adult, Older Adult) | NCT01635452 | PGL10-014 | PREMYA | May 2012 | April 2014 | March 2016 | July 9, 2012 | January 27, 2015 |
|
||||
55 | NCT00041899 | Completed | Comparison of Blood Levels of Two Formulations of the Selective Hormone Receptor Modulator CDB-2914 |
|
|
Interventional |
Phase 1 |
|
NIH |
|
15 | Female | Child, Adult, Older Adult | NCT00041899 | 020219 02-CH-0219 |
May 2002 | March 2005 | July 19, 2002 | March 4, 2008 |
|
|||||
56 | NCT00755755 | Completed Has Results |
PGL4001 Versus Placebo in Uterine Myomas |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
241 | Female | 18 Years to 50 Years (Adult) | NCT00755755 | PGL07-021 | PEARLI | October 2008 | March 2010 | August 2010 | September 19, 2008 | December 13, 2012 | November 16, 2012 |
|
|
57 | NCT00929942 | Completed | Biodegradable Stents in Lung Transplantation |
|
|
Interventional |
Phase 1 |
|
Other |
|
|
10 | All | 18 Years and older (Adult, Older Adult) | NCT00929942 | 5237 | June 2009 | April 2011 | April 2011 | June 30, 2009 | July 22, 2011 |
|
|||
58 | NCT03537768 | Recruiting | Study Comparing Emergency Contraception Effectiveness in Women Who Weight ≥ 80 kg |
|
|
Interventional |
Phase 4 |
|
Other / NIH |
|
|
1200 | Female | 18 Years to 40 Years (Adult) | NCT03537768 | CCN013C | July 12, 2018 | August 1, 2019 | August 1, 2019 | May 25, 2018 | August 1, 2018 |
|
|||
59 | NCT02859337 | Recruiting | Effectiveness of Orally Dosed Emergency Contraception in Obese Women - UPA |
|
|
Interventional |
Phase 4 |
|
Other / NIH |
|
|
112 | Female | 18 Years to 35 Years (Adult) | NCT02859337 | OHSU IRB 016291 | UPA-Obesity | May 30, 2017 | October 2021 | October 2021 | August 9, 2016 | September 25, 2018 |
|
||
60 | NCT01569113 | Completed | Assessment of Effects on Ovarian Activity of a Combined Oral Contraceptive Pill When Preceded by the Intake of ellaOne® or Placebo. |
|
|
Interventional |
Phase 4 |
|
Industry |
|
|
76 | Female | 18 Years to 35 Years (Adult) | NCT01569113 | 2914-015 | March 2012 | August 2012 | August 2012 | April 2, 2012 | June 13, 2013 |
|
|||
61 | NCT00551616 | Completed | Safety and Efficacy of CDB-2914 in Comparison to Levonorgestrel for Emergency Contraception |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
2321 | Female | 16 Years and older (Child, Adult, Older Adult) | NCT00551616 | 2914-004 | April 2007 | April 2009 | April 2009 | October 31, 2007 | June 17, 2010 |
|
|||
62 | NCT02465814 | Completed | Assess Safety and Efficacy of Vilaprisan in Patients With Uterine Fibroids |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
120 | Female | 18 Years to 50 Years (Adult) | NCT02465814 | 17541 2014-004221-41 |
ASTEROID 2 | June 2015 | October 2016 | October 2016 | June 9, 2015 | November 22, 2016 |
|
||
63 | NCT02620319 | Unknown † | Biodegradable Stents in the Management of Stenoses of the Large Airways |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
30 | All | 18 Years and older (Adult, Older Adult) | NCT02620319 | NT 14146-3/2013 NT14146 |
May 2013 | December 2016 | December 2016 | December 3, 2015 | June 17, 2016 |
|
|||
64 | NCT02078414 | Completed | Continued Use of Effective Contraception After Use of Emergency Contraception |
|
Observational |
|
Other |
|
|
7 | Female | 18 Years to 45 Years (Adult) | NCT02078414 | RFSU1 | March 2014 | February 2015 | March 5, 2014 | November 26, 2015 |
|
||||||
65 | NCT01252069 | Completed | PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata (PEARLIII-extension Study) |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
132 | Female | 18 Years to 48 Years (Adult) | NCT01252069 | PGL09-027 | January 2011 | August 2013 | January 2014 | December 2, 2010 | January 13, 2016 |
|
|||
66 | NCT01156857 | Completed | PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
209 | Female | 18 Years to 48 Years (Adult) | NCT01156857 | PGL09-026 | PEARLIII | July 2010 | November 2011 | February 2012 | July 5, 2010 | January 15, 2016 |
|
||
67 | NCT00280709 | Completed | Biliary Metal Stent Study: Metal Stents for Management of Distal Malignant Biliary Obstruction |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
400 | All | 20 Years and older (Adult, Older Adult) | NCT00280709 | ELLA | January 2006 | October 2008 | August 2010 | January 23, 2006 | August 10, 2011 |
|
|||
68 | NCT00089414 | Terminated Has Results |
Treatment of Menstrually Related Disorders With Continuous v. Interrupted Oral Contraceptives |
|
|
Interventional |
Phase 2 |
|
NIH |
|
|
5 | Female | 18 Years to 45 Years (Adult) | NCT00089414 | 040221 04-M-0221 |
July 2004 | June 2010 | June 2010 | August 5, 2004 | August 25, 2017 | January 2, 2017 |
|
||
69 | NCT03829696 | Not yet recruiting New |
Advance Provision of Medication Abortion |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
50 | Female | 18 Years to 40 Years (Adult) | NCT03829696 | A128753_02 | May 2019 | April 2020 | April 2020 | February 4, 2019 | February 4, 2019 | ||||
70 | NCT00496288 | Recruiting | Prophylactic Irradiation to the Contralateral Breast for BRCA Mutation Carriers Undergoing Treatment for Breast Cancer |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
240 | Female | 30 Years to 90 Years (Adult, Older Adult) | NCT00496288 | 102/07 (HT4351) | March 2008 | March 2023 | July 4, 2007 | April 5, 2011 |
|
||||
71 | NCT00740831 | Completed Has Results |
PGL4001 Versus GnRH-agonist in Uterine Myomas |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
301 | Female | 18 Years to 50 Years (Adult) | NCT00740831 | PGL07-022 | PEARLII | August 2008 | January 2010 | June 2010 | August 25, 2008 | December 17, 2012 | November 16, 2012 |
|
|
72 | NCT02863445 | Recruiting | Effectiveness of Orally Dosed Emergency Contraception in Obese Women - LNG |
|
|
Interventional |
Phase 4 |
|
Other / NIH |
|
|
80 | Female | 18 Years to 35 Years (Adult) | NCT02863445 | OHSU IRB 16291 | EC-Obesity | May 30, 2017 | October 2021 | October 2021 | August 11, 2016 | September 25, 2018 |
|
||
73 | NCT02353286 | Completed | Endoscopic Treatment of Benign Biliary Strictures and Cystic Duct Leakages With a Novel Biodegradable Biliary Stent |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
14 | All | 18 Years and older (Adult, Older Adult) | NCT02353286 | Biodegradable Biliary stent | May 2014 | December 31, 2017 | December 31, 2017 | February 2, 2015 | May 14, 2018 |
|
|||
74 | NCT03240523 | Active, not recruiting | Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
1000 | Female | 18 Years and older (Adult, Older Adult) | NCT03240523 | 15789 2016-002855-48 |
ASTEROID 5 | July 31, 2017 | September 16, 2021 | September 16, 2021 | August 7, 2017 | February 5, 2019 |
|
||
75 | NCT01834027 | Completed Has Results |
The Effect of Jazz on Postoperative Pain and Stress in Patients Undergoing Elective Hysterectomy |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
56 | Female | 18 Years to 75 Years (Adult, Older Adult) | NCT01834027 | IRB 40925 | March 2013 | January 2014 | January 2014 | April 17, 2013 | April 15, 2016 | August 22, 2014 |
|
||
76 | NCT03774368 | Recruiting | Targeted Video Messaging About Emergency Contraception |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
150 | Female | 18 Years to 29 Years (Adult) | NCT03774368 | 2018P001764 | January 15, 2019 | December 31, 2019 | December 31, 2019 | December 13, 2018 | January 16, 2019 |
|
|||
77 | NCT03412526 | Not yet recruiting | Adoptive Cell Therapy Following a Reduced Intensity, Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Ovarian |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
15 | Female | 18 Years to 80 Years (Adult, Older Adult) | NCT03412526 | SHEBA-16-3568-JS-TIL Ovarian | January 31, 2018 | February 1, 2021 | February 1, 2022 | January 26, 2018 | January 30, 2018 |
|
|||
78 | NCT02580578 | Active, not recruiting | A Multicenter Prospective Non-Interventional Study Assessing the Management of Canadian Women With Uterine Fibroids |
|
|
Observational |
|
Industry |
|
|
1501 | Female | 18 Years and older (Adult, Older Adult) | NCT02580578 | CMO-CAN-WH-0412 | July 31, 2015 | February 13, 2020 | February 13, 2020 | October 20, 2015 | August 8, 2018 |
|
||||
79 | NCT01629563 | Completed | PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
451 | Female | 18 Years to 50 Years (Adult) | NCT01629563 | PGL11-006 | PEARLIV | June 2012 | January 2015 | January 2015 | June 27, 2012 | December 8, 2015 |
|
||
80 | NCT03604185 | Recruiting | Effects of Short-term Choir Participation on Auditory Perception in Hearing-aided Older Adults. |
|
|
Interventional |
Not Applicable |
|
Other / Industry |
|
|
60 | All | 50 Years and older (Adult, Older Adult) | NCT03604185 | 2018-089 | September 1, 2018 | November 1, 2019 | August 1, 2020 | July 27, 2018 | February 8, 2019 |
|
|||
81 | NCT01242280 | Completed | Self-expandable Esophageal Stent Versus Balloon Tamponade in Refractory Esophageal Variceal Bleeding. |
|
|
Interventional |
Phase 3 |
|
Other |
|
|
28 | All | 18 Years and older (Adult, Older Adult) | NCT01242280 | PE08001 | January 2010 | June 2014 | June 2014 | November 17, 2010 | February 5, 2015 |
|
|||
82 | NCT02847338 | Recruiting | Comparison of Optimal Hypertension Regimens |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
1320 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT02847338 | AO94005 | AIMHY-INFORM | November 2016 | November 2020 | November 2021 | July 28, 2016 | July 9, 2018 |
|
||
83 | NCT02321163 | Unknown † | Electrical Stimulation for Attenuating Muscle Atrophy |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
105 | All | 35 Years to 80 Years (Adult, Older Adult) | NCT02321163 | HMRF12131991 | February 2016 | December 2016 | May 2017 | December 22, 2014 | February 25, 2016 |
|
|||
84 | NCT03796832 | Not yet recruiting | Footwear and Exercise for Knee Osteoarthritis (FiREwORK Trial) |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
106 | All | 50 Years and older (Adult, Older Adult) | NCT03796832 | B670201835057 G013318N U1111-1225-9954 |
FiREwORK | February 1, 2019 | June 30, 2021 | December 31, 2021 | January 8, 2019 | January 8, 2019 |
|
||
85 | NCT01152983 | Unknown † | Safety and Performance Evaluation of the Rapid Ring Device |
|
|
Interventional |
Phase 1 Phase 2 |
|
Industry |
|
|
30 | All | 18 Years and older (Adult, Older Adult) | NCT01152983 | CTIL - CL-001 | August 2010 | November 2010 | November 2010 | June 29, 2010 | June 29, 2010 |
|
|||
86 | NCT03268733 | Recruiting | The Effects of Folic Acid on Sudanese Women With Polycystic Ovary Syndrome |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
90 | Female | 20 Years to 40 Years (Adult) | NCT03268733 | Folic acid in PCOS | FolicacidPCOS | September 1, 2017 | September 1, 2018 | September 1, 2019 | August 31, 2017 | August 31, 2017 |
|
||
87 | NCT01799668 | Unknown † | Therapists' Preferences for Client Characteristics and Their Influence on the Therapeutic Alliance |
|
Observational |
|
Other |
|
|
200 | All | 18 Years and older (Adult, Older Adult) | NCT01799668 | 0001-13 HYMC | February 2013 | October 2013 | October 2013 | February 27, 2013 | February 27, 2013 |
|
|||||
88 | NCT03429920 | Recruiting | Effect of Fermented Soy Based Product on Cardiometabolic Risk Factors |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
31 | All | 35 Years to 75 Years (Adult, Older Adult) | NCT03429920 | 2160353 | FS | September 23, 2018 | March 24, 2019 | March 31, 2020 | February 12, 2018 | October 29, 2018 |
|
||
89 | NCT00228202 | Unknown † | Genotyping of Cytomegalovirus From Patients in Israel |
|
Observational |
|
Other |
|
100 | All | Child, Adult, Older Adult | NCT00228202 | SHEBA-05-3867-NK-CTIL Sara Orzi MSc thesis |
September 2005 | September 28, 2005 | August 18, 2006 |
|
||||||||
90 | NCT01988077 | Terminated | Clinical Evaluation of Yervoy in Combination With Adoptive T Cell Transfer for Metastatic Melanoma Patients |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
2 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT01988077 | Ipilimumab TIL | October 2013 | May 2016 | October 2018 | November 20, 2013 | May 23, 2017 |
|
|||
91 | NCT03353402 | Recruiting | Fecal Microbiota Transplantation (FMT) in Metastatic Melanoma Patients Who Failed Immunotherapy |
|
|
Interventional |
Phase 1 |
|
Other |
|
|
40 | All | 18 Years and older (Adult, Older Adult) | NCT03353402 | SHEBA-17-3956-GM | November 30, 2017 | December 30, 2019 | December 30, 2021 | November 27, 2017 | December 21, 2018 |
|
|||
92 | NCT03189927 | Not yet recruiting | BD-Covered Stent for Benign Esophageal Strictures: a Safety and Feasibility Study |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
15 | All | 18 Years and older (Adult, Older Adult) | NCT03189927 | NL.59222.091.16 | BIDARCA | July 1, 2017 | July 1, 2018 | January 1, 2019 | June 16, 2017 | June 16, 2017 | |||
93 | NCT00287131 | Unknown † | Adoptive Cell Therapy Following Non-myeloablate Chemotherapy in Metastatic Melanoma Patients |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
70 | All | 18 Years and older (Adult, Older Adult) | NCT00287131 | SHEBA-04-3518-JS-CTIL | January 2006 | December 2012 | November 2013 | February 6, 2006 | March 29, 2012 |
|
|||
94 | NCT03675152 | Recruiting | Treatment of Spondylolysisin Pediatric Patients. |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
60 | All | 8 Years to 20 Years (Child, Adult) | NCT03675152 | T45/2016 | June 12, 2016 | December 21, 2021 | December 21, 2022 | September 18, 2018 | October 5, 2018 |
|
|||
95 | NCT02979119 | Recruiting | The European Paediatric Network for Haemophilia Management ( PedNet Registry) |
|
|
Observational |
|
Other |
|
|
2200 | All | Child, Adult, Older Adult | NCT02979119 | Version 5.1 June 2014 | PedNet | June 2014 | December 2019 | December 2019 | December 1, 2016 | November 6, 2017 |
|
|||
96 | NCT03191942 | Recruiting | Variation of Orthokeratology Lens Treatment Zone (VOLTZ) Study |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
60 | All | 6 Years to 11 Years (Child) | NCT03191942 | HSEARS20170118004 | June 14, 2017 | June 2020 | August 2020 | June 19, 2017 | June 21, 2017 |
|
|||
97 | NCT02203695 | Recruiting | Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy |
|
|
Interventional |
Phase 2 |
|
Other / Industry |
|
|
122 | Male | 18 Years to 100 Years (Adult, Older Adult) | NCT02203695 | J1454 IRB00030471 |
March 2015 | August 2020 | August 2025 | July 30, 2014 | October 12, 2018 |
|
|||
98 | NCT00294476 | Unknown † | IVIG in the Treatment of Metastatic Cancers of the Prostate, Colon and Melanoma |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
30 | All | 18 Years and older (Adult, Older Adult) | NCT00294476 | GCan-01 | July 2005 | February 22, 2006 | October 12, 2006 |
|
|||||
99 | NCT02251288 | Completed | A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine |
|
|
Interventional |
Phase 1 |
|
NIH |
|
|
62 | All | 18 Years to 47 Years (Adult) | NCT02251288 | 13-0087 | May 18, 2015 | August 17, 2018 | August 17, 2018 | September 29, 2014 | February 15, 2019 |
|
|||
100 | NCT00169884 | Unknown † | The Efficacy of a Cognitive-Behavioural Intervention in Deliberate Self-Harm Patients |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
120 | All | 15 Years to 35 Years (Child, Adult) | NCT00169884 | 2100.0068 | March 2002 | March 2007 | September 15, 2005 | February 1, 2006 |
|
† Study has passed its completion date and status has not been verified in more than two years.